Floatz logo

HUMAN FAECAL MATTER

Myelodysplastic Syndromes

University Hospital, Clermont-Ferrandother_biologicalPhase 2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
65/ 100

Competitive context

137 Active assets in the Myelodysplastic Syndromes cohort.

Asset / SponsorPhaseRating
Daunorubicin
OHSU Knight Cancer Institute
Phase 3BB
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 4BB
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
Romidepsin
Sawa Ito, MD
Phase 4BB

View all 50 →

Same molecule, other indications

HUMAN FAECAL MATTER is also rated in:

cirrhosis of liverDormant
BB
Indicative ·
66 / 100
View asset →
hepatic encephalopathyDormant
B
Indicative ·
61 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →